Article Text

Download PDFPDF
CASE REPORT
Medical diligence uncovers fallopian tube cancer after abnormal Pap test
  1. Cara Buskmiller1,
  2. Brittany Cline2 and
  3. Francisco Xynos1
  1. 1 Obstetrics, Gynecology, and Women’s Health, Saint Louis University, St Louis, Missouri, USA
  2. 2 School of Medicine, Saint Louis University, St Louis, Missouri, USA
  1. Correspondence to Dr Francisco Xynos, francisco.xynos{at}health.slu.edu

Abstract

The fallopian tube has received attention as an origin of high-grade pelvic malignancies. This is a case of bilateral fallopian tube cancer discovered after an abnormal Pap test. A 62-year-old woman with a history of one term delivery had atypical glandular cells on a Pap test. She had an unsatisfactory colposcopy and a normal transvaginal ultrasound. A loop electrode excision procedure and hysteroscopy with dilation and curettage revealed atypical glandular cells concentrated in floating balls. CA-125 was 10 U/mL. A robotic hysterectomy revealed histopathological stage IIIA serous carcinoma arising from both fallopian tubes. She received six cycles of carboplatin and paclitaxel. After chemotherapy, she has no evidence of disease at 5 years. Fallopian tube carcinoma is a differential diagnosis of abnormal glandular cells on a Pap test. Diagnosis by systematic pursuit of abnormal tests can lead to successful treatment of a small disease burden.

  • screening (oncology)
  • cervical screening
  • obstetrics and gynaecology
  • cancer intervention
  • gynaecological cancer
View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors CB and BC reviewed the record, obtained photomicrographs, obtained consent and prepared the manuscript. FX directed patient care, advised development of the manuscript and agreed with the final draft.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Obtained.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.